Results
Xilio Therapeutics Inc.
02/24/2026 | Press release | Distributed by Public on 02/24/2026 06:30
Proxy Results (Form 8-K)
Item 5.07. Submission of Matters to a Vote of Security Holders.
On February 23, 2026, Xilio Therapeutics, Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting"). The following is a summary of the matters voted on at the Special Meeting and the results of the votes on such matters.
1.
The Company's stockholders approved the amendment to the Company's restated certificate of incorporation, as amended, to effect a reverse stock split of the Company's issued shares of common stock at a ratio within a range of not less than 1-for-2 and not greater than 1-for-30, with the exact ratio within such range and the implementation and timing of such reverse stock split to be determined at the sole discretion of the Company's board of directors, without further approval or authorization of the Company's stockholders ("Proposal 1"). The results of the stockholders' vote with respect to such approval were as follows:
|
Votes For |
Votes Against |
Votes Abstaining |
Broker Non-Votes |
|||
|
55,438,144 |
1,521,271 |
33,539 |
0 |
2.
The Company's stockholders approved the proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 1. The results of the stockholders' vote with respect to such approval were as follows:
|
Votes For |
Votes Against |
Votes Abstaining |
Broker Non-Votes |
|||
|
55,461,067 |
1,491,733 |
40,154 |
0 |
Xilio Therapeutics Inc. published this content on February 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 24, 2026 at 12:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]